Abbott Laboratories has released its 2025 10-K report, detailing robust financial performance with net sales of $44.3 billion and significant growth in medical devices and established pharmaceutical products segments. The report highlights strategic initiatives such as key
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ABBOTT LABORATORIES SEC 10-K Report
Abbott Laboratories has released its 2025 10-K report, detailing robust financial performance with net sales of $44.3 billion and significant growth in medical devices and established pharmaceutical products segments. The report highlights strategic initiatives such as key